Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Jan Opatrny"'
Autor:
Josef Jirak, Jan Bruthans, Milan Hromádka, Richard Rokyta, Jan Opatrny, David Suchy, Otto Mayer, Roman Miklík
Publikováno v:
Journal of comparative effectiveness research. 10(12)
Aim: Although uric acid has antioxidant effects, hyperuricemia has been established as an indicator of increased cardiovascular mortality in various patient populations. Treatment of asymptomatic hyperuricemia in patients with acute myocardial infarc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5ff48fa1e42232e91de4c9cbb4bc753
https://pubmed.ncbi.nlm.nih.gov/34114471
https://pubmed.ncbi.nlm.nih.gov/34114471
Autor:
Tomas Kovarnik, Jiri Holy, Ludek Haman, Klára Benešová, Jan Opatrny, Petr Neuzil, Petr Peichl, Prague Trial Investigators, Milos Taborsky, Martina Novackova, Pavel Červinka, Jiri Jarkovsky, Veronika Lekesova, Petr Kala, Dalibor Herman, Stepan Havranek, Pavel Osmancik, Vlastimil Vančura, Marian Branny, Pavel Hala, Martin Poloczek, Petr Widimsky, Petr Tousek, Josef Stasek, David Zemánek, Vivek Y. Reddy, Jan Chovančík
Publikováno v:
Journal of the American College of Cardiology. 75(25)
Background Percutaneous left atrial appendage closure (LAAC) is noninferior to vitamin K antagonists (VKAs) for preventing atrial fibrillation (AF)–related stroke. However, direct oral anticoagulants (DOACs) have an improved safety profile over VKA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51e7d27474b33df8060938b94523c1b3
https://pubmed.ncbi.nlm.nih.gov/32586586
https://pubmed.ncbi.nlm.nih.gov/32586586